How sodium channels in blood-vessel lining cells affect artery stiffness

Epithelial sodium channels in endothelial cells and arterial stiffening

NIH-funded research University of Missouri-Columbia · NIH-11302705

This work looks at whether blocking specific sodium channels in the cells that line blood vessels can reduce artery stiffening linked to obesity and related heart and blood vessel problems.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Missouri-Columbia NIH-funded
Lab location1 site (Columbia, United States)
Project IDNIH-11302705 on NIH RePORTER

What this research studies

From a patient viewpoint, the team is examining how a hormone receptor and linked sodium channels in blood-vessel lining cells make arteries stiffer in obesity. They focus on a cell enzyme (ECUSP8) that prevents breakdown of those channels, how the channels move inside cells, and how tiny vesicles carrying channel proteins affect neighboring vessel cells. The researchers use laboratory models to change the receptor, the enzyme, and the channels to measure effects on cell and vessel stiffness, inflammation, and oxidative stress. Results may point to drugs that interrupt this pathway to help keep arteries more flexible.

Who could benefit from this research

Good fit: People with obesity who have signs of arterial stiffness or increased cardiovascular risk would be the most relevant candidates for future therapies informed by this work.

Not a fit: People whose artery stiffness stems from unrelated genetic connective-tissue disorders or who have healthy, flexible arteries are less likely to benefit from these specific findings.

Why it matters

Potential benefit: If successful, this research could point to new treatments that prevent or reverse artery stiffening in people with obesity, lowering their risk of heart attack and stroke.

How similar studies have performed: Earlier animal and cell studies have tied mineralocorticoid receptors and epithelial sodium channels to vessel stiffening, but targeting ECUSP8 and exosomal channel trafficking is a newer and less-tested approach.

Where this research is happening

Columbia, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Cardiovascular Diseases
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.